Search Results 501-510 of 14782 for anti-TNF drugs

  1. A Study to Evaluate the Safety, Effectiveness and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment - Mayo Clinic

    To evaluate a new oral treatment, ABI-M201 (or placebo) in individuals with mild to moderate Ulcerative Colitis who have sustained an inadequate response to ...

  2. Factor Xiii (Intravenous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Corifact; Tretten. Descriptions. Factor ...

  3. Naproxen (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  4. Drug Discovery, Design and Optimization for Novel Therapeutics: Thomas Caulfield - Mayo Clinic Research

    Caulfield works with the Precision Cancer Therapeutics Program within the Center for Individualized Medicine to make novel anti-cancer agents in conjunction ...

  5. Antihemophilic Factor (Recombinant) Pegylated-Aucl (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  6. Azelastine And Fluticasone (Nasal Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Dymista. Descriptions. Azelastine and fluticasone ...

  7. Peginterferon Beta-1a (Intramuscular Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Plegridy Pen; Plegridy Pen Starter Pack. Descriptions.

  8. Moxifloxacin (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  9. Antihemophilic Factor (Recombinant), Fc-Vwf-Xten Fusion Protein-Ehtl (Intravenous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Altuviiio. Descriptions.

  10. Mayo Clinic Q and A: Immunotherapy and breast cancer

    Known as checkpoint inhibitors, or PD-1/PD-L1 pathway inhibitors, this treatment aims to prevent the deactivation and increase the body's anti-tumor immune ...